Plotkin's Vaccines
7th Edition
Published on 26. June 2017
Book
Hardback
1720 pages
978-0-323-35761-6 (ISBN)
Description
From the development of each vaccine to its use in reducing disease, Plotkin's Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field.
Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues - plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyzes the cost-benefit and cost-effectiveness of different vaccine options.
Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine.
Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines.
Features a new chapter on maternal immunization.
Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues - plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyzes the cost-benefit and cost-effectiveness of different vaccine options.
Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine.
Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines.
Features a new chapter on maternal immunization.
Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Reviews / Votes
Doody's Core Titles (R) 20222018 BMA Awards: Winner, Public Health
More details
Edition
7th edition
Language
English
Place of publication
Philadelphia
United States
Target group
Professional and scholarly
Illustrations
Approx. 600 illustrations (600 in full color)
Dimensions
Height: 276 mm
Width: 216 mm
Weight
3510 gr
ISBN-13
978-0-323-35761-6 (9780323357616)
Schweitzer Classification
Other editions
New editions
Walter A. Orenstein | Paul A. Offit | Kathryn M. Edwards
Plotkin's Vaccines
Book
05/2023
8th Edition
Elsevier
€347.50
Available immediately
Additional editions
E-Book
04/2017
7th Edition
Elsevier
€253.99
Available for download
Previous edition
Book
10/2012
6th Edition
Saunders
€377.48
Article exhausted; check for reprint
Persons
Author
Professor of Medicine and Pediatrics, and Global Health, Emory University; Associate Director, Emory Vaccine Center, Atlanta GA; Bill & Melinda Gates Foundation, Seattle, WA; Former Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
Chief, Division of Infectious Diseases, Director, Vaccine Education Center, The Children's Hospital of Philadelphia; Professor of Pediatrics, Maurice R. Hilleman Professor of Vaccinology, Perelman School of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Professor of Pediatrics Emerita, USA
Content
Section 1: General Aspects of Vaccination
1. A Short History of Vaccination
2. Vaccine Immunology
3. Correlates of Protection
4. The Vaccine Industry
5. Vaccine Manufacturing
6. Evolution of Adjuvants Across the Centuries
7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
8. Passive Immunization
9. General Immunization Practices
Section 2: Licensed Vaccines and Vaccines in Development
10. Adenovirus Vaccines
11. Anthrax Vaccines
12. Biodefense and Special Pathogen Vaccines
13. Cancer Vaccines
14. Cholera Vaccines
15. Combination Vaccines
16. Cytomegalovirus Vaccines
17. Dengue Vaccines
18. Diarrhea Caused by Bacteria
19. Diphtheria Toxoid
20. Ebola Vaccines
21. Enterovirus 71
22. Epstein-Barr Virus Vaccines
23. Haemophilus influenzae Type b Vaccines
24. Hepatitis A Vaccines
25. Hepatitis B Vaccines
26. Hepatitis C Vaccines
27. Hepatitis E Vaccines
28. Herpes Simplex Virus Vaccines
29. Human Immunodeficiency Virus Vaccines
30. Human Papillomavirus Vaccines
31. Inactivated Influenza Vaccines
32. Influenza Vaccine-Live
33. Japanese Encephalitis Vaccines
34. Lyme Disease Vaccines
35. Malaria Vaccines
36. Maternal Immunization
37. Measles Vaccines
38. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
39. Meningococcal Capsular Group B Vaccines
40. Mumps Vaccines
41. Noninfectious Disease Vaccines
42. Norovirus Vaccines
43. Parasitic Disease Vaccines
44. Pertussis Vaccines
45. Plague Vaccines
46. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
47. Pneumococcal Polysaccharide Vaccines
48. Poliovirus Vaccine-Inactivated
49. Poliovirus Vaccine-Live
50. Rabies Vaccines
51. Respiratory Syncytial Virus Vaccines
52. Rotavirus Vaccines
53. Rubella Vaccines
54. Smallpox and Vaccinia
55. Staphylococcus aureus Vaccines
56. Streptococcus Group A Vaccines
57. Streptococcus Group B Vaccines
58. Tetanus Toxoid
59. Tickborne Encephalitis Vaccines
60. Tuberculosis Vaccines
61. Typhoid Fever Vaccines
62. Varicella Vaccines
63. Yellow Fever Vaccines
64. Zika Virus
65. Zoster Vaccines
Section 3: New Technologies
66. Technologies for Making New Vaccines
67. Development of Gene-Based Vectors for Immunization
68. Technologies to Improve Immunization
Section 4: Vaccination of Special Groups
69. Vaccination of Immunocompromised Hosts
70. Vaccination of Human Immunodeficiency Virus-Infected Persons
71. Vaccines for International Travel
72. Vaccines for Healthcare Personnel
Section 5: Public Health and Regulatory Issues
73. Immunization in the United States
74. Immunization in Europe
75. Immunization in the Asia-Pacific Region
76. Immunization in Developing Countries
77. Community Protection
78. Economic Analyses of Vaccine Policies
79. Regulation and Testing of Vaccines
80. Regulation of Vaccines in Europe
81. Regulation of Vaccines in Low- and Middle-Income Countries
82. Vaccine Safety
83. Legal Issues
84. Ethics
Appendix: Websites and Applications for Mobile Devices with Information about Immunization
1. A Short History of Vaccination
2. Vaccine Immunology
3. Correlates of Protection
4. The Vaccine Industry
5. Vaccine Manufacturing
6. Evolution of Adjuvants Across the Centuries
7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
8. Passive Immunization
9. General Immunization Practices
Section 2: Licensed Vaccines and Vaccines in Development
10. Adenovirus Vaccines
11. Anthrax Vaccines
12. Biodefense and Special Pathogen Vaccines
13. Cancer Vaccines
14. Cholera Vaccines
15. Combination Vaccines
16. Cytomegalovirus Vaccines
17. Dengue Vaccines
18. Diarrhea Caused by Bacteria
19. Diphtheria Toxoid
20. Ebola Vaccines
21. Enterovirus 71
22. Epstein-Barr Virus Vaccines
23. Haemophilus influenzae Type b Vaccines
24. Hepatitis A Vaccines
25. Hepatitis B Vaccines
26. Hepatitis C Vaccines
27. Hepatitis E Vaccines
28. Herpes Simplex Virus Vaccines
29. Human Immunodeficiency Virus Vaccines
30. Human Papillomavirus Vaccines
31. Inactivated Influenza Vaccines
32. Influenza Vaccine-Live
33. Japanese Encephalitis Vaccines
34. Lyme Disease Vaccines
35. Malaria Vaccines
36. Maternal Immunization
37. Measles Vaccines
38. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
39. Meningococcal Capsular Group B Vaccines
40. Mumps Vaccines
41. Noninfectious Disease Vaccines
42. Norovirus Vaccines
43. Parasitic Disease Vaccines
44. Pertussis Vaccines
45. Plague Vaccines
46. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
47. Pneumococcal Polysaccharide Vaccines
48. Poliovirus Vaccine-Inactivated
49. Poliovirus Vaccine-Live
50. Rabies Vaccines
51. Respiratory Syncytial Virus Vaccines
52. Rotavirus Vaccines
53. Rubella Vaccines
54. Smallpox and Vaccinia
55. Staphylococcus aureus Vaccines
56. Streptococcus Group A Vaccines
57. Streptococcus Group B Vaccines
58. Tetanus Toxoid
59. Tickborne Encephalitis Vaccines
60. Tuberculosis Vaccines
61. Typhoid Fever Vaccines
62. Varicella Vaccines
63. Yellow Fever Vaccines
64. Zika Virus
65. Zoster Vaccines
Section 3: New Technologies
66. Technologies for Making New Vaccines
67. Development of Gene-Based Vectors for Immunization
68. Technologies to Improve Immunization
Section 4: Vaccination of Special Groups
69. Vaccination of Immunocompromised Hosts
70. Vaccination of Human Immunodeficiency Virus-Infected Persons
71. Vaccines for International Travel
72. Vaccines for Healthcare Personnel
Section 5: Public Health and Regulatory Issues
73. Immunization in the United States
74. Immunization in Europe
75. Immunization in the Asia-Pacific Region
76. Immunization in Developing Countries
77. Community Protection
78. Economic Analyses of Vaccine Policies
79. Regulation and Testing of Vaccines
80. Regulation of Vaccines in Europe
81. Regulation of Vaccines in Low- and Middle-Income Countries
82. Vaccine Safety
83. Legal Issues
84. Ethics
Appendix: Websites and Applications for Mobile Devices with Information about Immunization